Supplementary Table 1S from A Randomized Phase II/III Study of Naptumomab Estafenatox + IFNα Versus IFNα in Renal Cell Carcinoma: Final Analysis with Baseline Biomarker Subgroup and Trend Analysis
openalex(2023)
Key words
Renal Cell Carcinoma
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined